The Endothelial Dysfunction Blocker ameliorates cognitive impairment by inhibiting blood‐brain barrier (BBB) dysfunction and neuroinflammation in the 5XFAD mouse model of Alzheimer's disease
Our findings demonstrate that CU71 treatment ameliorates cognitive impairment by inhibiting BBB dysfunction and neuroinflammation in the 5XFAD mouse model of Alzheimer's disease.
Authors
- Cho‐Rong Bae (ORCID: https://orcid.org/0000-0002-5390-3479)
- Yeomyeong Kim
- Young‐Guen Kwon (ORCID: https://orcid.org/0000-0002-1534-2455)
- Dongyeop Kim
Institutions
- University of Seoul (KR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_100124
- Primary Topic
- Barrier Structure and Function Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00